Related Experiment Video

Updated: May 27, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

[Extracorporeal membrane oxygenation of a child with severe chemical pneumonia]

Anders Bastholm Bille1, Karen Damgaard Pedersen, Steen Hertel

  • 1Anæstesi- og Operationsklinikken, Juliane Marie Centret, Rigshospitalet, Denmark. andersbbille@dadlnet.dk

Ugeskrift for Laeger
|November 29, 2011
PubMed

Insights

A child with severe respiratory distress after lamp oil ingestion improved with extracorporeal membrane oxygenation (ECMO). This life support technology was crucial for recovery, leading to a normal lung X-ray post-treatment.

Area of Science:

  • Pediatric Critical Care Medicine
  • Toxicology
  • Respiratory Medicine

Background:

  • Hydrocarbon ingestion, such as lamp oil, can cause severe acute respiratory distress syndrome (ARDS) in children.
  • Standard mechanical ventilation strategies may be insufficient for managing severe hydrocarbon-induced ARDS.

Observation:

  • A 13-month-old child ingested lamp oil, leading to severe ARDS, pneumothorax, and emphysema.
  • Initial mechanical ventilation, including high-frequency oscillation, failed to stabilize the patient's condition.

Findings:

  • Veno-arterial extracorporeal membrane oxygenation (ECMO) was initiated on day three and provided life support for nine days.
  • Following ECMO and two additional days of conventional ventilation, the child was successfully extubated.
  • Four months post-treatment, the child showed normal lung X-rays and no residual disease signs.

Implications:

  • ECMO can be a life-saving intervention for pediatric patients with severe, refractory hydrocarbon-induced respiratory failure.
  • This case highlights the potential severity of lamp oil ingestion and the critical role of advanced respiratory support.
  • Successful ECMO treatment can lead to complete recovery in pediatric ARDS patients.

More Related Videos

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen01:16

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...